CNX-2006 5mg | Purity Not Available
Selleck Chemicals
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
More Information Supplier PageSearch Results
GSK650394 100mg | Purity Not Available
Selleck Chemicals
GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor with IC50 of 62 nM and 103 nM for SGK1 and SGK2, respectively.
More Information Supplier PageThiamet G 25mg | Purity Not Available
Selleck Chemicals
Thiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37,000-fold selectivity over human lysosomal –hexosaminidase.
More Information Supplier PageRepSox (E-616452) 10mg | Purity Not Available
Selleck Chemicals
RepSox (E-616452, SJN 2511, ALK5 Inhibitor II) is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation in cell-free assays, respectively.
More Information Supplier PageRepSox (E-616452) 25mg | Purity Not Available
Selleck Chemicals
RepSox (E-616452, SJN 2511, ALK5 Inhibitor II) is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation in cell-free assays, respectively.
More Information Supplier PageAlvelestat (AZD9668) 25mg | Purity Not Available
Selleck Chemicals
Alvelestat (AZD9668, Avelestat) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases. Phase 2.
More Information Supplier PageAlvelestat (AZD9668) 5mg | Purity Not Available
Selleck Chemicals
Alvelestat (AZD9668, Avelestat) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases. Phase 2.
More Information Supplier PageOAC1 50mg | Purity Not Available
Selleck Chemicals
OAC1 (Oct4-activating compound 1, BAS 00287861) can enhance the efficiency of reprogramming. OAC1 can activate both Oct4 and Nanog promoter-driven luciferase reporter genes.
More Information Supplier PageLosmapimod 50mg | Purity Not Available
Selleck Chemicals
Losmapimod is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. P38 MAPKs are involved in cell differentiation, apoptosis and autophagy. Phase 3.
More Information Supplier PageLosmapimod 10mg | Purity Not Available
Selleck Chemicals
Losmapimod is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. P38 MAPKs are involved in cell differentiation, apoptosis and autophagy. Phase 3.
More Information Supplier Page